Atrion (NASDAQ:ATRI) Sees Large Volume Increase

Atrion Co. (NASDAQ:ATRI - Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately 11,008 shares were traded during mid-day trading, a decline of 36% from the previous session's volume of 17,223 shares.The stock last traded at $413.00 and had previously closed at $399.83.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Atrion from a "hold" rating to a "sell" rating in a research report on Monday.

Atrion Stock Performance

The firm has a market capitalization of $713.31 million, a price-to-earnings ratio of 36.74 and a beta of 0.60. The business's 50-day moving average is $401.31 and its two-hundred day moving average is $364.59.

Atrion (NASDAQ:ATRI - Get Free Report) last announced its earnings results on Thursday, February 29th. The medical instruments supplier reported $3.65 EPS for the quarter. The firm had revenue of $43.58 million for the quarter. Atrion had a net margin of 11.46% and a return on equity of 8.07%.

Atrion Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 15th were issued a dividend of $2.20 per share. The ex-dividend date was Thursday, March 14th. This represents a $8.80 annualized dividend and a yield of 2.17%. Atrion's dividend payout ratio (DPR) is currently 79.78%.

Institutional Trading of Atrion

Hedge funds have recently bought and sold shares of the stock. Wesbanco Bank Inc. acquired a new stake in shares of Atrion during the first quarter worth $205,000. Penn Mutual Asset Management LLC acquired a new stake in shares of Atrion during the fourth quarter worth $1,949,000. Tower Research Capital LLC TRC lifted its holdings in shares of Atrion by 592.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 270 shares of the medical instruments supplier's stock worth $102,000 after buying an additional 231 shares in the last quarter. Quadrant Capital Group LLC acquired a new stake in shares of Atrion during the fourth quarter worth $36,000. Finally, Jump Financial LLC acquired a new stake in shares of Atrion during the fourth quarter worth $234,000. 66.19% of the stock is currently owned by institutional investors and hedge funds.

Atrion Company Profile

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.